Evidence map›Paper›PMID 40531580›Full record

ArticleJournal of the American Society of Nephrology : JASN2025

Discontinuation of Renin-Angiotensin System Inhibitors during Acute Kidney Injury Episode and All-Cause Mortality: Target Trial Emulation Studies.

Sheng Nie, Yanqin Li, Yinfang Sun, Shan Chen, Xian Shao, Mingzhen Pang, Shiyu Zhou, Licong Su, Ruixuan Chen, Fan Luo and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sheng NieDivision of Nephrology, State Key Laboratory of Multi-Organ Injury Prevention and Treatment, National Clinical Research Center for Kidney Disease, Nanfang Hospital, Southern Medical University, Guangzhou, China.ORCID 0000-0002-8267-7909
Yanqin Li
Yinfang Sun
Shan Chen
Xian ShaoORCID 0000-0003-1720-6788
Mingzhen Pang
Shiyu Zhou
Licong SuORCID 0000-0002-3085-909
Ruixuan ChenORCID 0000-0002-2925-9484
Fan Luo
Xin XuORCID 0000-0002-6324-5211
Fan Fan HouORCID 0000-0003-3117-7418
CRDS Study Investigators

Funding

Guangdong Provincial Clinical Research 2020B1111170013Key Technologies R&D Program of Guangdong Province 2023B1111030004National Key R&D Program of China 2021YFC2500200National Key R&D Program of China 2021YFC2500204National Natural Science Foundation of China 81900626National Natural Science Foundation of China 82030022Program of Introducing Talents of Discipline to Universities D18005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACE inhibitorsAKIAKI and critical caremortality

Identifiers

PMID40531580
PMCPMC12677820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.